Article
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy.
Neurology - 10 Jul 2012
Bello Luca, Piva Luisa, Barp Andrea, Taglia Antonella, Picillo Esther, Vasco Gessica, Pane Marika, Previtali Stefano C, Torrente Yvan, Gazzerro Elisabetta, Motta Maria Chiara, Grieco Gaetano S, Napolitano Sara, Magri Francesca, D'Amico Adele, Astrea Guja, Messina Sonia, Sframeli Maria, Vita Gian Luca, Boffi Patrizia, Mongini Tiziana, Ferlini Alessandra, Gualandi Francesca, Soraru' Gianni, Ermani Mario, Vita Giuseppe, Battini Roberta, Bertini Enrico, Comi Giacomo P, Berardinelli Angela, Minetti Carlo, Bruno Claudio, Mercuri Eugenio, Politano Luisa, Angelini Corrado, Hoffman Eric P, Pegoraro Elena
Abstract excerpt
OBJECTIVE: To test the effect of the single nucleotide polymorphism -66 T>G (rs28357094) in the osteopontin gene (SPP1) on functional measures over 12 months in Duchenne muscular dystrophy (DMD). METHODS: This study was conducted on a cohort of ambulatory patients with DMD from a network of Italian neuromuscular centers, evaluated longitudinally with the north star ambulatory assessment (NSAA) and the 6-minute...
Topics
- Adolescent
- Adult
- Child
- Child, Preschool
- Clinical Trials as Topic
